JANX vs. USLM

Last updated Jun 4, 2026

JANX (Janux Therapeutics, Inc.) and USLM (United States Lime & Minerals, Inc.) are both stocks. JANX operates in Biotechnology (Healthcare), while USLM operates in Building Materials (Basic Materials). Over the past 3 years, JANX returned -0.20%/yr vs 42.25%/yr for USLM. At a 0.21 correlation, their price movements are largely independent.

Performance

JANX vs. USLM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JANX achieves a -1.52% return, which is significantly higher than USLM's -11.07% return.

JANX

• 1D: -1.38%
• 1M: -5.76%
• YTD: -1.52%
• 6M: -20.57%
• 1Y: -46.56%
• 3Y*: -0.20%
• 5Y*: —
• 10Y*: —

USLM

• 1D: -0.87%
• 1M: -0.05%
• YTD: -11.07%
• 6M: -10.57%
• 1Y: -0.40%
• 3Y*: 42.25%
• 5Y*: 31.61%
• 10Y*: 26.42%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JANX vs. USLM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
JANX Janux Therapeutics, Inc.	-1.52%	-74.22%	398.97%	-18.53%	-33.25%	-21.55%
USLM United States Lime & Minerals, Inc.	-11.07%	-9.59%	188.91%	64.34%	9.84%	-8.79%

Correlation

The correlation between JANX and USLM is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.21
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (All Time) Calculated using the full available price history since Jun 14, 2021	0.21

Fundamentals

EPS JANX : -$1.84 USLM : $6.07
PS Ratio JANX : 39.07 USLM : 6.21
Total Revenue (TTM) JANX : $21.61M USLM : $369.31M
Gross Profit (TTM) JANX : $8.44M USLM : $177.91M
EBITDA (TTM) JANX : -$134.03M USLM : $185.83M

Return for Risk

JANX vs. USLM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JANX

JANX Risk / Return Rank: 17
JANX Sharpe Ratio Rank: 14
JANX Sortino Ratio Rank: 20
JANX Omega Ratio Rank: 17
JANX Calmar Ratio Rank: 14
JANX Martin Ratio Rank: 17

USLM

USLM Risk / Return Rank: 38
USLM Sharpe Ratio Rank: 40
USLM Sortino Ratio Rank: 36
USLM Omega Ratio Rank: 36
USLM Calmar Ratio Rank: 39
USLM Martin Ratio Rank: 39

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JANX vs. USLM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JANX	USLM	Difference
Sharpe ratio Return per unit of total volatility	-0.63	-0.01	-0.62
Sortino ratio Return per unit of downside risk	-0.43	0.26	-0.69
Omega ratio Gain probability vs. loss probability	0.92	1.04	-0.12
Calmar ratio Return relative to maximum drawdown	-0.72	-0.02	-0.70
Martin ratio Return relative to average drawdown	-1.10	-0.04	-1.06
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JANX vs. USLM - Sharpe Ratio Comparison

The current JANX Sharpe Ratio is -0.63, which is lower than the USLM Sharpe Ratio of -0.01. The chart below compares the historical Sharpe Ratios of JANX and USLM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JANX	USLM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.63	-0.01	-0.62
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.89	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.73	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.09	0.25	-0.34

Drawdowns

JANX vs. USLM - Drawdown Comparison

The maximum JANX drawdown since its inception was -83.14%, which is greater than USLM's maximum drawdown of -77.09%. Use the drawdown chart below to compare losses from any high point for JANX and USLM.

Drawdown Indicators

	JANX	USLM	Difference
Max Drawdown Largest peak-to-trough decline	-83.14%	-77.09%	-6.05%
Max Drawdown (1Y) Largest decline over 1 year	-64.94%	-26.55%	-38.39%
Max Drawdown (3Y) Largest decline over 3 years	-81.78%	-45.87%	-35.91%
Max Drawdown (5Y) Largest decline over 5 years	—	-45.87%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-45.87%	—
Current Drawdown Current decline from peak	-79.67%	-32.22%	-47.45%
Average Drawdown Average peak-to-trough decline	-52.01%	-27.35%	-24.66%
Ulcer Index Depth and duration of drawdowns from previous peaks	42.42%	10.85%	+31.57%

Volatility

JANX vs. USLM - Volatility Comparison

Janux Therapeutics, Inc. (JANX) has a higher volatility of 9.11% compared to United States Lime & Minerals, Inc. (USLM) at 8.50%. This indicates that JANX's price experiences larger fluctuations and is considered to be riskier than USLM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JANX	USLM	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.11%	8.50%	+0.61%
Volatility (6M) Calculated over the trailing 6-month period	82.02%	32.02%	+50.00%
Volatility (1Y) Calculated over the trailing 1-year period	74.22%	40.58%	+33.64%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	131.36%	35.90%	+95.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	131.36%	36.37%	+94.99%

Dividends

JANX vs. USLM - Dividend Comparison

JANX has not paid dividends to shareholders, while USLM's dividend yield for the trailing twelve months is around 0.23%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
JANX Janux Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
USLM United States Lime & Minerals, Inc.	0.23%	0.20%	0.15%	0.35%	0.57%	0.50%	0.56%	6.52%	0.76%	0.70%	0.66%	0.91%

Financials

Frequently Asked Questions

Can I hold both JANX and USLM in my portfolio?

JANX and USLM have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JANX or USLM?

JANX has higher volatility (9.11%) compared to USLM (8.50%). In terms of maximum drawdown, JANX dropped -83.14% vs USLM's -77.09%.

Which has better risk-adjusted returns?

USLM currently has the higher Sharpe Ratio (-0.01 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.